Terns Pharmaceuticals Inc... (TERN)
4.67
0.10 (2.19%)
At close: Jan 15, 2025, 1:38 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -90.21M | -60.34M | -50.16M | -40.57M | -68.82M | -18.02M |
| Depreciation & Amortization | 881.00K | 1.03M | 512.00K | 394.00K | 195.00K | 65.00K |
| Stock-Based Compensation | 25.54M | 10.77M | 8.15M | 1.69M | 668.00K | 234.00K |
| Other Working Capital | 142.00K | -315.00K | -3.15M | 6.21M | 1.05M | -840.00K |
| Other Non-Cash Items | -5.03M | 81.00K | 879.00K | 2.92M | -246.00K | -307.00K |
| Deferred Income Tax | 141.00K | 392.00K | 219.00K | 693.00K | 206.00K | 307.00K |
| Change in Working Capital | 1.29M | -1.04M | -1.43M | 5.06M | 1.77M | -352.00K |
| Operating Cash Flow | -67.39M | -49.11M | -41.83M | -29.81M | -66.22M | -18.07M |
| Capital Expenditures | -52.00K | -275.00K | -340.00K | -584.00K | -900.00K | -244.00K |
| Acquisitions | n/a | 22.00K | 119.36K | -7.28K | 2.96K | 12.04M |
| Purchase of Investments | -275.78M | -139.73M | -166.30M | -715.00K | -58.38M | -6.95M |
| Sales Maturities Of Investments | 237.85M | 117.73M | 46.94M | 7.99M | 55.43M | 2.42M |
| Other Investing Acitivies | n/a | -22.00K | -119.36K | 7.28K | -2.96K | -4.53K |
| Investing Cash Flow | -37.99M | -22.27M | -119.70M | 6.69M | -3.86M | -4.78M |
| Debt Repayment | n/a | n/a | n/a | 16.88M | 58.00K | 58.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.02M | -158.00K | -1.97M | 68.64M | 4.00K | 99.70M |
| Financial Cash Flow | 41.95M | 167.50M | 134.39M | 85.52M | 62.00K | 99.76M |
| Net Cash Flow | -63.31M | 95.54M | -27.16M | 62.48M | -70.15M | 77.02M |
| Free Cash Flow | -67.44M | -49.38M | -42.17M | -30.39M | -67.12M | -18.32M |